BGI is granted patent in 16 countries for non-invasive prenatal genetic test technology

(BGI Shenzhen) The European Patent Office has issued patent number EP2561103B1 for invention to BGI for its independently researched non-invasive prenatal genetic test technology. This technology has been developed by BGI in connection with the provision of its market leading NIPT, the NIFTY test. The patent is effective in 15 member countries including England, Belgium, Spain, Slovenia, Hungary, Sweden, Turkey, Switzerland, Italy, France, Denmark, Germany, Czech Republic, Poland and Romania.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news